OZEMPIC 0.5 mg, solution for injection in a pre-filled pen pen, 3 ml + 4 needles
Brand page: Ozempic (semaglutide) — all forms and strengths in France
Active ingredients: Semaglutide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 3 ml + 4 needlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OZEMPIC 0,5 mg, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 cartouche en verre de 3 mL dans stylo pré-rempli multidose jetable + 4 aiguilles
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61400703CIP73032215CIP133400930322154Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SÉMAGLUTIDEsolution | 0,5 mg · une dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.